Clinical Trial Search

Primary: Absolute Change in Coronary Cross-sectional Area (in mm²) Within the Vericiguat Group as Assessed by Magnetic Resonance Imaging (MRI) — -1.11; 0.40 mm^2 — p=0.0005

Primary: Leukoglycemic Index (LGI) — 1.081; 1.230 mg/dL*cells per mm^3

Primary: Change in Post-exercise Coronary Vasodilator Reserve — -4; 2 % change

Primary: Change in Clinicians' Treatment Decision After Age/Sex/Gene Expression Score — 38; 1; 1; 0 number of subjects — p=<0.001

Primary: Rates of Major Cardiac Events (AMI or Cardiac Death) Within 30 Days — 0; 0; 0; 10 Participants

Primary: Percent Change in Coronary Cross Sectional Area (CSA) From Rest to That During Isometric Handgrip Exercise (IHE) — -1.70; 2.71; -0.39; 2.04 Percent change from rest…

Primary: Change From Baseline in Coronary Flow Reserve — 0.62 ratio

Primary: Angina Episode Frequnecy — 2.28; 1.68 episodes per week

Primary: Change in Coronary Flow Reserve (CFR) — 3.04 ratio — p=0.0137

Primary: Low Density Lipoprotein - Cholesterol — -6.74; 0.53 mg/dL — p=0.27

Primary: Acceptability Measured by the Client Satisfaction Questionnaire — 30.57 score on a scale

Primary: Feasibility as Measured by the Number of Total Scheduled Intervention Sessions (CHW Counseling Sessions, Doctor's Visits, Phone Calls) Attended — 589 Scheduled sessions

Primary: Number of Major Adverse Cardiac Events (MACE) — 9; 6; 2; 119 Participants

Primary: Adherence to Refills and Medications Scale (ARMS) — 12.03; 12.18 units on a scale

Primary: Acceptability as Measured by the Acceptability of Intervention Measure (AIM) — 4.82 score on a scale

Primary: Total Mortality. — 138 Participants.

Primary: Quantification of Myocardial Blood Volume — 3.63; 1.23 seconds^-1

Primary: Per-Vessel Sensitivity of CTP in the Detection of Myocardial Perfusion Defects During Pharmacological Stress as Compared to Invasive Angiography. — 79 percentage of…

Primary: Percentage of Participants With Target Lesion Failure (TLF) at 12 Months Post-Index Procedure by Bayesian Estimation — 6.32; 8.90 Percentage of participants

Primary: Mean Resting E/E' — 7.01 ml/min/kg — p==0.14

Primary: All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. — 51; 53 Participants

Primary: Percent Change in LDL-Cholesterol — -68.78; -27.58 percent change

Primary: Number of Participants With First Occurrence of Any Component of Composite MACE (CV Death, MI, or Stroke) — 439; 472 Participants — p=0.121

Primary: Percent Agreement Between Coronary Calcium Score (CCS) and National Cholesterol Education Program (NCEP) Guidelines — 18 percent agreement

Primary: Change in Carotid Intima-media Thickness From Baseline to Year 1 — 0.766; 0.765; 0.758; 0.768 millmeter — p=0.7279

Primary: The Sensitivity and Specificity of ECG for Acute Coronary Occlusion. — 767; 282; 16 Participants

Primary: Number of Flow-limiting Coronary Artery Stenosis on CT — 8 Coronary arteries

Primary: The Primary Outcome Measure is Plasma Levels of TNF Alpha. — 507 ng/mL

Primary: COPD Diagnosis — 39 participants

Primary: Number of Participants Assessed for Relative Change in the Index of Microcirculatory Resistance Before and After Ranolazine Therapy — 7 Participants